Document 0194
 DOCN  M95A0194
 TI    Is self-sufficiency financially viable and ethically justifiable?--legal
       aspects.
 DT    9510
 AU    Newdick C; Department of Law, University, Reading, UK.
 SO    Blood Coagul Fibrinolysis. 1994 Dec;5 Suppl 4:S37-8. Unique Identifier :
       AIDSLINE MED/95315442
 AB    There is no legislation specifically designed to compensate haemophilia
       patients who have been damaged by defective blood products. But there is
       a general regime, created as a result of the thalidomide tragedy, which
       deals with defective 'products'. It was introduced at the European level
       by the European Directive on Product Liability in 1985 and has been
       given effect in England by the Consumer Protection Act 1987. The rights
       of haemophilia patients who are injured by defective blood products
       depends on this Directive.
 DE    Blood Proteins/ADVERSE EFFECTS/ECONOMICS/*SUPPLY & DISTRIBUTION  Child
       *Ethics, Medical  Hemophilia/THERAPY  Human  HIV Infections/PREVENTION &
       CONTROL/TRANSMISSION  Iatrogenic Disease  Jurisprudence  *Legislation,
       Medical  Male  Risk  Safety  Therapeutics/ECONOMICS  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).